In addition, exosomal TF-Ag-α measurement may potentially be utilized as a noninvasive companion diagnostic platform for cancer-specific assessment of other membrane biomarkers expressed on the cell surface, e.g., to evaluate dynamic changes in HER2 expression status. The gene discussed is ERBB2; the disease is cancer.